Tata Chemicals Limited today announced its financial results for the quarter and year ended March 31, 2026, reporting consolidated revenue from operations at ₹3,438 crore and EBITDA at ₹274 crore for Q4FY26.
The company’s consolidated revenue declined 2% compared to Q4FY25, primarily due to lower realizations driven by reduced exports from the US, partially offset by higher volumes in India. EBITDA stood at ₹274 crore as against ₹327 crore in Q4FY25, impacted by subdued pricing across geographies and increased fixed costs, including the impact of steep depreciation of the Indian Rupee.
An exceptional charge of ₹1,837 crore was recorded on account of impairment of goodwill in the US business, along with a deferred tax asset write-off of ₹159 crore. Profit After Tax (before exceptional items and NCI) stood at ₹(279) crore compared to ₹(12) crore in Q4FY25. Net debt (excluding leases) stood at ₹5,961 crore as of March 31, 2026.
The Board recommended a dividend of ₹11 per share.
Commenting on the results, R. Mukundan, Managing Director s CEO, Tata Chemicals Limited, said:
“During Ǫ4FY2c the global soda ash markets remained adequately supplied and the supply overhang continue to exert pressure on pricing. The challenging external environment amid ongoing geopolitical tensions in the Middle East led to uncertainty and limited visibility on any immediate change in market conditions.
Despite the challenging external environment, the Company’s standalone performance has been supported by higher volumes and disciplined cost management, resulting in a resilient operating performance. Mithapur facility (India) achieved production of 1 MTPA of Soda Ash during FY2c. However, the Company’s consolidated performance has been sharply impacted by continuing unsustainable unremunerative prices across geographies particularly in Southeast Asia. In US, impairment charge of ₹ 1,837 Cr of goodwill & ₹ 182 Cr of deferred tax assets write-off recognized amidst the current soda ash export market conditions.
We successfully completed the acquisition of Novabay Pte. Limited, Singapore during the quarter, as announced earlier. This acquisition aligns with our strategy of expanding high-margin specialty chemicals and strengthening our presence in key global markets. It enhances our ability to offer differentiated, value-added solutions and supports our long-term growth agenda.
The Board also approved a ₹100 crore investment to debottleneck salt capacity at our Mithapur plant by 82,500 TPA. This will strengthen our core consumer products portfolio and support long-term, sustainable growth while meeting rising demand for high-quality iodised salt.
In the midst of a challenging and volatile operating environment, our focus remains resolutely on safeguarding margins, preserving cash flows, and maintaining a strong and resilient balance sheet. We are navigating this phase with prudence and disciplined capital deployment. These actions are aimed at reinforcing the Company’s financial strength and positioning us to emerge from the current cycle with sustained stability and long-term value creation for our investors.”